Clinical Trials Logo

Lung Diseases clinical trials

View clinical trials related to Lung Diseases.

Filter by:

NCT ID: NCT03893409 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

GIRH Chronic Obstructive Pulmonary Disease Observational Study

Start date: August 10, 2018
Phase:
Study type: Observational

The purpose of this study is to establish the large COPD cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.

NCT ID: NCT03892629 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Baduanjin Exercise for Patients With GOLD 2-3 Stable COPD on Pulmonary Rehabilitation

Start date: April 2019
Phase: N/A
Study type: Interventional

Chronic Obstructive Pulmonary Disease (COPD) is a disease with a very high morbidity and mortality rate. When the lung function drops lower and lower, patients will bear great affliction physically and mentally. How to improve the quality of life in patients with COPD is a hot topic in the study of COPD now. Baduanjin, as one of the traditional Chinese qigong exercises, has the features of generous stretch, soft consistency, dynamic but static, which is an appropriate movement pattern for COPD patients.

NCT ID: NCT03890224 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients

Start date: July 4, 2019
Phase: N/A
Study type: Interventional

The hypothesis of this study is that any of 3 modalities of home non- invasive ventilation (NIV) compared to 'no NIV' (=hospital NIV) will reduce re-admission to hospital or death in COPD patients who remain persistently hypercapnic following an exacerbation requiring NIV.

NCT ID: NCT03889964 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Exercise Capacity in COPD

Start date: March 1, 2019
Phase:
Study type: Observational

In this study, cardiopulmonary exercise will be assessed to characterize the relevance of severity of COPD and coexisting cardiovascular comorbidities for exercise capacity.

NCT ID: NCT03888131 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient

FORSYYN
Start date: July 30, 2018
Phase: Phase 3
Study type: Interventional

The purpose of the study is to demonstrate the non-inferiority of CHF1535 pMDI versus Symbicort® Turbohaler® in terms of lung function parameters and patients reported outcomes and to assess its safety and tolerability.

NCT ID: NCT03887364 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Icing and Airflow Stimulation in Obstructive Lung Diseases

Start date: February 2, 2018
Phase: N/A
Study type: Interventional

A randomized controlled trial in which icing and airflow stimulation for reduction of dyspnea in patients of obstructive lung disease was done which is characterized as condition of infection described by constant improvement of perpetual constraint of flow of air that is partially reversible and incorporates chronic bronchitis, emphysema and small airway diseases . The tools used were RR, Spirometry, Saturation, Borg Scale, MRC scale, shuttle walk test and St George's Respiratory Questionnaire (St.GRQ) score. Pulse oximeter measured the saturation levels and respiratory rates were alse observed. Borg scale measured rate of perceived exertion ranges from 6(easy physical activity) and 20(worst activity) and MRC measure dyspnea levels. In St.GRQ score between 1 to 8 is symptoms related and 9 to 17 was activity related.Literature review indicate that icing and airflow stimulation reduce dyspnea in patients of obstructive lung diseases.

NCT ID: NCT03885128 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Intra Versus Extra-thoracic Oscillations in Chronic Obstructive Pulmonary Disease

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Chronic Obstructive Pulmonary Disease (COPD) is the fourth-leading cause of death. It is a progressive illness that requires life-long treatment.Promoting airway clearance (AC) using mucolytics together with airway clearance techniques (ACTs) form the basis for pulmonary therapy in COPD care.Therefore, new airway clearance modalities are required to decrease the detrimental effects of accumulated secretions in COPD. One of the devices used in AC is the high frequency chest wall oscillation (The Vest). HFCWO involves the use of an inflatable vest/jacket that covers the chest and is attached to an air pulse-generating compressor which rapidly inflates and deflates the vest, producing oscillations to the chest wall of 5-25 Hz. Another new airway clearance modality is oscillating positive expiratory pressure(Quake) which combines PEP therapy with high frequency oscillations.

NCT ID: NCT03882372 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

Nasal High Flow to Maintain the Benefits of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients

PPR-NHF
Start date: July 22, 2019
Phase: N/A
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is a major cause of disability and mortality worldwide. This systemic disease progressively leads to dyspnea and exercise capacity impairment. Pulmonary rehabilitation effectively improves exercise capacity, dyspnea and quality of life in patients with COPD. However, its benefits progressively fade over time due to several factors such as the lack of regular exercise activity, dyspnea, airway secretions, hematosis impairment and acute exacerbations which can lead to hospitalization and accelerated muscle wasting. Nasal high flow (NHF) is a support used to deliver heated and humidified high flow air (up to 60 L/min) through nasal canula providing promising physiological benefits such as positive airway pressure or upper airway carbon dioxide washout. It can be used in association with oxygen and offers the advantage to overtake the patient's inspiratory flow, providing a stable inspired fraction of oxygen. Nasal high flow has widely been studied in pediatric and adult intensive care units and seems better than conventional oxygen therapy and as effective as noninvasive ventilation with regards to mortality to treat hypoxemic acute respiratory failure. More recently, several studies have shown that long-term nasal high flow could contribute to improve exercise capacity, dyspnea, airway secretion removal, hematosis, reduced acute exacerbations and subsequent hospitalizations in patients with COPD. Based on these results, the primary aim of this study is to assess whether long-term nasal high flow treatment can help COPD patients to better maintain their endurance capacity following a course of pulmonary rehabilitation.

NCT ID: NCT03872362 Completed - Neoplasms Clinical Trials

Radiomics Multifactorial Biomarker for Pulmonary Nodules

RMBPN
Start date: July 11, 2018
Phase:
Study type: Observational

The investigators aim to investigate the utility of radiomics to differentiate malignant nodules from benign nodules and invasive adenocarcinoma from non-invasive adenocarcinoma.

NCT ID: NCT03871933 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Autonomic Function in COPD and Risk for Atrial Fibrillation

Start date: March 1, 2019
Phase:
Study type: Observational

In the presented study, autonomic function as well as risk for atrial fibrillation will be assessed to characterize the relation between risk of atrial fibrillation and autonomic function.